Drugs / MTC01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05911997 | Jan 2024 → Nov 2025 | Clostridium difficile colitis | Icahn School of Medicine at Mount Sinai | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTC01 | “With this platform, we conducted the first direct comparison of the same bacterial strains from donor-sourced FMT compared to an in vitro manufactured 15-strain LBP drug...” PMID 42230754 ↗ Jun 2026 |
| Modality | Other / unclassified | “an in vitro manufactured 15-strain LBP drug product, MTC01” PMID 42230754 ↗ Jun 2026 |